Archive: Ross Marchand
Ross Marchand is a Catalyst Policy Fellow and the director of policy for the Taxpayers Protection Alliance. He focuses on a range of issues, ranging from health-care reform to internet regulation to Postal Service-related issues. Ross is an alumnus of the Mercatus Center MA Fellowship at George Mason University, where he received his MA in economics in 2016. He has interned for the Texas Public Policy Foundation and the American Legislative Exchange Council, analyzing and blogging on a variety of public policy issues.
This National Doctors’ Day, Let’s Show Our Appreciation
On National Doctors’ Day, policymakers can help doctors treat patients and keep the healthcare system working for everyone.
FDA Should Expand Options for Coronavirus Patients
The FDA must roll back the red tape holding up care for millions of Americans.
HSAs Can Save Millions of Smokers’ Lives – with the Right Rules
By leveling the tax playing field, the federal government can give millions of smokers a chance to save their lives.
Healthcare Sharing Ministries Are a Godsend to More than a Million Patients
HCSMs are far from perfect, but they at least afford patients some incentive to shop around while delivering large, overall premium savings.
Andrew Yang’s Misguided Obsession with Automation
Acknowledging that there is room for improvement is different from kowtowing to a dystopian narrative based on zero evidence.
As Patients Enter New Decade, Obamacare Remains in the Rear View Mirror
By allowing more choice, policymakers can give patients a chance to enjoy this new year and many more to come.
Thanks to Crony Capitalism, Healthcare Competition Is Flatlining for Consumers
It’s time to end these crony practices and bring back some much-needed competition to the healthcare sector.
From the Russia Investigation to FBI Mass Surveillance, Government Snooping Is Out of Control
The best way to curb government malfeasance is by limiting the scope of warrants and surveillance in the first place.
Congress Must Axe Christmas Tree Tax
The Consumer Product Safety Commission has been having a field day regulating any and all festive lights under Santa’s sleigh.
An Alzheimer’s Cure May Be On the Horizon—But Only With Right-Sized Regulations
The FDA could and should be more open-minded in evaluating the evidence in its drug approval decisions.
An International Agency Could Erode American Liberties on U.S. Taxpayers’ Dime
Attorney-client privilege is a cornerstone of Western law and is worth preserving.
Did Midas Touch Medicare?
Despite its positive reputation, Medicare isn’t exactly a harbinger of health.